365 related articles for article (PubMed ID: 29058038)
1. Drug-drug interactions and their harmful effects in hospitalised patients: a systematic review and meta-analysis.
Zheng WY; Richardson LC; Li L; Day RO; Westbrook JI; Baysari MT
Eur J Clin Pharmacol; 2018 Jan; 74(1):15-27. PubMed ID: 29058038
[TBL] [Abstract][Full Text] [Related]
2. Drug-Drug Interactions and Actual Harm to Hospitalized Patients: A Multicentre Study Examining the Prevalence Pre- and Post-Electronic Medication System Implementation.
Li L; Baker J; Quirk R; Deidun D; Moran M; Salem AA; Aryal N; Van Dort BA; Zheng WY; Hargreaves A; Doherty P; Hilmer SN; Day RO; Westbrook JI; Baysari MT
Drug Saf; 2024 Jun; 47(6):557-569. PubMed ID: 38478349
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of clinically manifested drug interactions in hospitalized patients: A systematic review and meta-analysis.
Gonzaga de Andrade Santos TN; Mendonça da Cruz Macieira G; Cardoso Sodré Alves BM; Onozato T; Cunha Cardoso G; Ferreira Nascimento MT; Saquete Martins-Filho PR; Pereira de Lyra D; Oliveira Filho AD
PLoS One; 2020; 15(7):e0235353. PubMed ID: 32609783
[TBL] [Abstract][Full Text] [Related]
4. Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis.
Dechanont S; Maphanta S; Butthum B; Kongkaew C
Pharmacoepidemiol Drug Saf; 2014 May; 23(5):489-97. PubMed ID: 24616171
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of potential drug-drug interactions in patients with heart failure at hospital discharge.
Straubhaar B; Krähenbühl S; Schlienger RG
Drug Saf; 2006; 29(1):79-90. PubMed ID: 16454536
[TBL] [Abstract][Full Text] [Related]
6. Drug-drug interactions in pediatric oncology patients.
Balk TE; van der Sijs IH; van Gelder T; Janssen JJB; van der Sluis IM; van Leeuwen RWF; Engels FK
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28205376
[TBL] [Abstract][Full Text] [Related]
7. Countrywide prevalence of critical drug interactions in Hungarian outpatients: a retrospective analysis of pharmacy dispensing data.
Somogyi-Végh A; Ludányi Z; Erdős Á; Botz L
BMC Pharmacol Toxicol; 2019 May; 20(1):36. PubMed ID: 31151485
[TBL] [Abstract][Full Text] [Related]
8. Adverse drug reactions caused by drug-drug interactions in cardiovascular disease patients: introduction of a simple prediction tool using electronic screening database items.
Kovačević M; Vezmar Kovačević S; Radovanović S; Stevanović P; Miljković B
Curr Med Res Opin; 2019 Nov; 35(11):1873-1883. PubMed ID: 31328967
[No Abstract] [Full Text] [Related]
9. Potential drug-drug interactions associated with prolonged stays in the intensive care unit: a retrospective cohort study.
Moura C; Prado N; Acurcio F
Clin Drug Investig; 2011; 31(5):309-16. PubMed ID: 21344954
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of high-risk drug-drug interactions in paediatric inpatients: a retrospective, single-centre cohort analysis.
Dieu LW; Leuppi-Taegtmeyer AB; van den Anker J; Trachsel D; Gotta V
Swiss Med Wkly; 2019 Aug; 149():w20103. PubMed ID: 31422575
[TBL] [Abstract][Full Text] [Related]
11. Potential drug-drug interactions and admissions due to drug-drug interactions in patients treated in medical departments.
Fokter N; Mozina M; Brvar M
Wien Klin Wochenschr; 2010 Feb; 122(3-4):81-8. PubMed ID: 20213374
[TBL] [Abstract][Full Text] [Related]
12. Drug-drug interactions in inpatient and outpatient settings in Iran: a systematic review of the literature.
Nabovati E; Vakili-Arki H; Taherzadeh Z; Hasibian MR; Abu-Hanna A; Eslami S
Daru; 2014 Jun; 22(1):52. PubMed ID: 24965959
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical care.
Ramos GV; Guaraldo L; Japiassú AM; Bozza FA
J Clin Pharm Ther; 2015 Feb; 40(1):63-7. PubMed ID: 25329640
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of drug-drug interactions at hospital entry and during hospital stay of patients in internal medicine.
Vonbach P; Dubied A; Krähenbühl S; Beer JH
Eur J Intern Med; 2008 Oct; 19(6):413-20. PubMed ID: 18848174
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis assessing the prevalence of drug-drug interactions among hospitalized patients.
Aksoy N; Ozturk N
Pharmacoepidemiol Drug Saf; 2023 Dec; 32(12):1319-1330. PubMed ID: 37705139
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of drug interactions in hospitalised elderly patients: a systematic review.
de Oliveira LM; Diel JDAC; Nunes A; da Silva Dal Pizzol T
Eur J Hosp Pharm; 2021 Jan; 28(1):4-9. PubMed ID: 33355278
[TBL] [Abstract][Full Text] [Related]
17. Mapping the prevalence and nature of drug related problems among hospitalised children in the United Kingdom: a systematic review.
Sutherland A; Phipps DL; Tomlin S; Ashcroft DM
BMC Pediatr; 2019 Dec; 19(1):486. PubMed ID: 31829142
[TBL] [Abstract][Full Text] [Related]
18. Potential drug-drug interactions in outpatient department of a tertiary care hospital in Pakistan: a cross-sectional study.
Ismail M; Noor S; Harram U; Haq I; Haider I; Khadim F; Khan Q; Ali Z; Muhammad T; Asif M
BMC Health Serv Res; 2018 Oct; 18(1):762. PubMed ID: 30314487
[TBL] [Abstract][Full Text] [Related]
19. Potential drug-drug interactions in oncological adult inpatients at a Spanish hospital: epidemiology and risk factors.
Fernández de Palencia Espinosa MÁ; Díaz Carrasco MS; Alonso Romero JL; de la Rubia Nieto A; Espuny Miró A
Int J Clin Pharm; 2015 Dec; 37(6):1021-7. PubMed ID: 26391788
[TBL] [Abstract][Full Text] [Related]
20. Risk of potential drug-drug interactions among Brazilian elderly: a population-based, cross-sectional study.
Secoli SR; Figueras A; Lebrão ML; de Lima FD; Santos JL
Drugs Aging; 2010 Sep; 27(9):759-70. PubMed ID: 20809665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
